Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary

Introduction

Dr. Warrick Bishop, a cardiologist and CEO of the Healthy Heart Network, hosts this episode featuring Angela Paris, a cardiac nurse and heart disease prevention advocate. The episode explores Angela's personal cardiac health journey, including her family history of premature coronary artery disease and her proactive approach to heart screening, demonstrating how cardiac imaging can identify and manage cardiovascular risk before a major event occurs.

Key Takeaways:

• Family history of premature coronary artery disease (men at age 55 or less, women at age 60 or less) significantly increases personal cardiac risk and warrants early screening.

• Women develop coronary artery disease approximately 10 years later than men, which means screening for at-risk women should begin 5-10 years earlier than a male relative's event age to stay ahead of potential disease.

• Even light smoking (such as weekend-only smoking) has a measurable negative impact on cardiovascular health and can advance disease risk by approximately 10 years.

• CT coronary angiograms with contrast injection provide superior detail for identifying fatty plaque and tracking plaque progression compared to non-contrast calcium scoring, making side-by-side scan comparisons valuable for monitoring disease stability.

• The "C+ algorithm" (Calcium score, Calcium percentile, Low-attenuation plaque, Unfavorable remodeling, Stenosis, and Site/location) helps cardiologists identify the "weakest link in the chain" to assess overall cardiac risk accurately.

• Calcium score percentiles relative to age and gender provide more meaningful risk stratification than absolute calcium numbers alone.

• Left main coronary artery disease requires treatment regardless of plaque quality, as it represents the weakest link in coronary circulation and carries significant risk.

• Cholesterol-lowering therapy (statins) stabilizes fatty plaque and converts it to calcified plaque, making it difficult to assess plaque progression on repeat calcium scoring but more visible on contrast-enhanced CT angiograms.